0
Your cart

Your cart is empty

Books > Medicine > Nursing & ancillary services > Biomedical engineering

Buy Now

Synthetic Biology 2020: Frontiers in Risk Analysis and Governance (Hardcover, 1st ed. 2020) Loot Price: R4,606
Discovery Miles 46 060
Synthetic Biology 2020: Frontiers in Risk Analysis and Governance (Hardcover, 1st ed. 2020): Benjamin D. Trump, Christopher L....

Synthetic Biology 2020: Frontiers in Risk Analysis and Governance (Hardcover, 1st ed. 2020)

Benjamin D. Trump, Christopher L. Cummings, Jennifer Kuzma, Igor Linkov

Series: Risk, Systems and Decisions

 (sign in to rate)
Loot Price R4,606 Discovery Miles 46 060 | Repayment Terms: R432 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

Synthetic biology offers powerful remedies for some of the world's most intractable problems, but these solutions are clouded by uncertainty and risk that few strategies are available to address. The incentives for continued development of this emerging technology are prodigious and obvious, and the public deserves assurances that all potential downsides are duly considered and minimized accordingly. Incorporating social science analysis within the innovation process may impose constraints, but its simultaneous support in making the end products more acceptable to society at large should be considered a worthy trade-off. Contributing authors in this volume represent diverse perspectives related to synthetic biology's social sciences, and reflect on different areas of risk analysis and governance that have developed for the field. Such perspectives include leading scholarly discussion pertaining to risk assessment, governance, ethics, and communication. The chapters of this volume note that while the first twenty years of synthetic biology development have focused strongly on technological innovation and product development, the next twenty should emphasize the synergy between developers, policymakers, and publics to generate the most beneficial, well governed, and transparent technologies and products possible. Many chapters in this volume provide new data and approaches that demonstrate the feasibility for multi-stakeholder efforts involving policymakers, regulators, industrial developers, workers, experts, and societal representatives to share responsibilities in the production of effective and acceptable governance in the face of uncertain risk probabilities. A full consideration of such perspectives may prevent a world of draconian regulations based on an insufficient or incomplete understanding of the science that underpins synthetic biology, as well as any hesitancy or fear by the public to adopt its eventual products.

General

Imprint: Springer Nature Switzerland AG
Country of origin: Switzerland
Series: Risk, Systems and Decisions
Release date: December 2019
First published: 2020
Editors: Benjamin D. Trump • Christopher L. Cummings • Jennifer Kuzma • Igor Linkov
Dimensions: 235 x 155mm (L x W)
Format: Hardcover
Pages: 421
Edition: 1st ed. 2020
ISBN-13: 978-3-03-027263-0
Categories: Books > Medicine > Nursing & ancillary services > Biomedical engineering > General
Books > Professional & Technical > Biochemical engineering > Biotechnology > Genetic engineering
Books > Professional & Technical > Mechanical engineering & materials > Production engineering > Reliability engineering
LSN: 3-03-027263-X
Barcode: 9783030272630

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners